글로벌 광의학 기술 시장 – 2024-2031년

Global Photomedicine Technology Market - 2024-2031

상품코드MD1225
발행기관DataM Intelligence
발행일2024.08.06
페이지 수182 Pages
포맷PDF + EXCEL
커버리지Global

6,525,00011,775,000

보고서 요약(국문)

개요
전 세계 광의학 기술 시장은 2023년 36억 달러 규모에 달했으며, 2024년부터 2031년까지 연평균 8.2%의 성장률을 기록하며 2031년에는 67억 달러에 이를 것으로 예상됩니다.
광의학은 빛과 광생물학을 이용하여 질병을 치료하는 의학 분야입니다. 광의학 기술은 다양한 치료 및 진단 분야에 활용됩니다. 기존의 질병 진단 방법보다 발전된 광의학 기술은 종양학, 안과, 치과, 피부과, 통증 관리 등 광범위한 치료 분야에 사용됩니다.
이 시장은 첨단 레이저 기반 치료법의 도입 증가, 미용에 대한 인식 제고, 비침습적 시술 및 기술 발전에 대한 관심 증가 등의 요인에 의해 성장하고 있습니다.
시장 동향: 성장 동인
첨단 레이저 기반 치료법의 도입 증가
전 세계 광의학 기술 시장의 수요는 여러 요인에 의해 주도되고 있습니다. 레이저 치료법은 다양한 피부 질환에 대한 새로운 기술로 널리 활용되고 있습니다. 박피성 레이저와 비박피성 레이저는 표피와 진피의 서로 다른 층에 작용하여 다양한 피부 질환을 치료할 수 있습니다.
더욱이, 레이저 기술과 인공지능의 통합은 이 시장 성장을 견인할 것입니다. 2024년 1월 아스클레피온(Asclepion)의 레이저 기술 보고서에 따르면, 레이저 기기에 인공지능을 통합하는 것은 새로운 시대를 열어 시술자에게 전례 없는 정밀도, 효율성, 그리고 환자의 미용적 목표를 완벽하게 달성할 수 있는 결과를 제공할 것입니다.
또한, 업계 주요 업체들의 새로운 치료법 도입과 승인은 이 시장 성장을 촉진할 것입니다. 예를 들어, 2022년 11월 미국 식품의약국(FDA)은 아큐어 아크네(Accure Acne, Inc.)의 아큐어 레이저 시스템(Accure Laser System)을 경증에서 중증의 염증성 여드름 치료에 승인했습니다. 아큐어의 시스템은 FDA와 CE 마크 승인을 모두 획득한 최초의 1726nm 기반 레이저 기기입니다.
또한, 2024년 4월 비아레이즈(ViaLase)는 레이저 기술 발전을 위한 4천만 달러 규모의 투자 유치를 완료했다고 발표했습니다. 펨토초 레이저 영상 유도 고정밀 섬유주절제술을 수행하는 레이저 시스템 개발.
제한 요인
치료와 관련된 부작용 및 합병증, 광의학 시술의 높은 비용, 숙련된 전문가 부족, 제한적인 규제 체계 및 보험금 지급 정책과 같은 요인들이 시장 성장을 저해할 것으로 예상됩니다.
이 보고서에 대한 자세한 내용은 샘플을 요청하십시오.
세분화 분석
글로벌 광의학 기술 시장은 기술, 응용 분야, 최종 사용자 및 지역별로 세분화됩니다.
종양학 부문은 글로벌 광의학 기술 시장 점유율의 약 54.6%를 차지했습니다.
종양학 부문은 예측 기간 동안 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 피부암은 가장 위험한 암 유형 중 하나이며 전 세계적으로 다섯 번째로 흔하게 보고되는 암입니다. 2023년 1월 BMC 연구 간행물에 따르면, 미국 피부과학회(AAD)는 2022년 미국에서 매일 약 9,500명이 피부암 진단을 받았다고 밝혔습니다.
또한, 시장 주요 업체들이 다양한 질병 치료에 혁신적인 기술을 출시하고 연구를 진행함에 따라 시장 성장이 촉진될 것입니다. 2023년 12월 EurekAlert 보도 자료에 따르면, 캐나다 INRS 연구팀이 발견한 초고속 레이저 기술은 암 치료법을 개선하고 종양학 분야에서 방사선 치료의 효과를 높이는 데 기여할 수 있습니다.
2022년 3월 AAAS 간행물에 따르면, 로렌스 버클리 국립 연구소(버클리 연구소)의 생물학자와 물리학자들이 레이저로 생성된 양성자 빔을 이용한 새로운 암 치료 가능성을 모색하기 위해 협력하고 있습니다.
더불어, 주요 업체들의 신제품 출시와 승인 또한 시장 성장을 견인할 것입니다. 예를 들어, 2024년 1월, AngioDynamics, Inc.는 미국 식품의약국(FDA)이 말초동맥질환(PAD) 치료에 사용되는 Auryon Atherectomy System과 함께 사용할 수 있는 225cm 길이의 요골 접근 카테터인 Auryon XL 카테터를 승인했다고 발표했습니다.
지역 분석
북미는 전 세계 광의학 기술 시장 점유율의 약 43.4%를 차지했습니다.
북미 지역은 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상됩니다. 북미, 특히 미국에서 피부 질환과 암 발병률이 높은 것이 첨단 광의학 기술에 대한 수요를 촉진하고 있습니다. 미국 암 협회의 2022년 업데이트에 따르면, 미국에서는 약 190만 건의 새로운 암 환자가 발생했으며, 그중 유방암만 29만 560건에 달했습니다.
또한, 탈모 및 피부 문제와 같은 암 관련 부작용도 이 시장 성장을 견인하고 있습니다. 미국 탈모 협회(American Hair Loss Association)에 따르면 미국에서 8천만 명이 넘는 남녀가 탈모 문제로 고통받고 있으며, 2022년 팬데믹 이후 환자 수요가 400% 증가한 것으로 추산됩니다.
또한, 이 지역의 주요 업체들이 신제품 출시와 승인을 통해 시장 성장을 견인할 것으로 예상됩니다. 예를 들어, 2022년 3월, 알마(Alma)는 미국 제품 포트폴리오에 획기적인 두 가지 제품인 알마 TED와 CBD+ 프로페셔널 스킨케어 솔루션을 추가한다고 발표했으며, 이 제품들은 미국 피부과학회에서 출시되었습니다.
마찬가지로, 2024년 4월 베스트쿨(Bestqool)은 FDA 2등급 승인을 받은 내구성이 뛰어나고 다용도로 활용 가능한 적색광 치료기(RLT)를 출시했습니다. 이 독특한 기기는 습진 증상 완화 및 피부 건강 개선과 같은 다양한 피부 문제를 해결하도록 설계되었으며 의료 등급 제품 인증을 받았습니다.

또한, 2021년 7월, Cytrellis는 미국 식품의약국(FDA)으로부터 자사의 첫 번째 독자적인 제품인 마이크로코링 기술이 적용된 엘라코어 시스템(ellacor system)을 승인받았다고 발표했습니다. 이 시스템은 중안면부에서 하안면부의 중등도에서 중증 주름 치료에 사용됩니다. 최소 침습적인 이 분야 최초의 기기는 수술, 열 에너지 또는 흉터 없이 미세한 크기의 과도한 피부를 안전하고 효과적으로 제거합니다.
마찬가지로, 2024년 1월에는 Iridex가 망막 질환 및 녹내장 치료 분야에서 35년간의 레이저 혁신을 기념하며 미국 시장에 새로운 Iridex 532 및 Iridex 577 레이저를 출시했습니다.

시장 세분화
기술별
• 광역학 치료
• 광면역 치료
• 레이저
• 기타
응용 분야별
• 미용 및 피부과
o 제모
o 문신 제거
o 피부 재생
o 기타 응용 분야
• 안과
• 치과
• 종양학
• 통증 관리
• 상처 치유
• 기타 응용 분야
최종 사용자별
• 병원 및 클리닉
• 미용 센터
• 학술 및 연구 기관
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 스페인
o 이탈리아
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 한국
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
광의학 기술 시장의 주요 글로벌 기업으로는 Candela Corporation 등이 있습니다. Alma Lasers, Lumenis Be Ltd, PhotoMedex, biolitec Holding GmbH & Co KG, Beurer, Lumibird Medical, Koninklijke Philips N.V., THOR Photomedicine Ltd, Johnson & Johnson 등이 참여하고 있습니다.
주요 개발 사항
 2024년 5월, 국방보건국(DHA)의 지원을 받아 근골격계 손상 예방 및 치료를 위한 근골격계 손상 재활 연구(MIRROR)의 일환으로 시작된 군사 준비 태세 강화를 위한 광의학 프로그램이 출범했습니다.

 2024년 3월, 선도적인 바이오제약 회사인 CLINUVEL은 자사의 신약 SCENESSE(아파멜라노티드)와 광의학의 미래에 대해 광범위한 시장 설명회를 개최했습니다.

 2022년 5월, 루메니스 비(Lumenis Be)는 옵티라이트(OptiLight)가 경쟁이 치열한 메드테크 브레이크스루 어워드(MedTech Breakthrough Award)에서 “안과 분야 최고의 신기술 솔루션” 상을 수상했다고 발표했습니다.

 2021년 1월, 테라라이트(TheraLight, LLC)는 캐나다 보건부(Health Canada)가 차세대 광선 치료 기술을 적용한 전신 광생체조절 시스템인 테라라이트 360(TheraLight 360)의 캐나다 내 사용 승인을 받았다고 발표했습니다.

보고서 구매 이유:

• 기술, 응용 분야, 최종 사용자 및 지역별 글로벌 광의학 기술 시장 세분화를 시각화하고 주요 상업 자산 및 기업을 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴합니다.

• 모든 세그먼트를 포함한 글로벌 광의학 기술 시장 수준의 다양한 데이터가 담긴 엑셀 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 기업의 핵심 제품을 모두 포함하는 제품 맵핑 엑셀 파일을 제공합니다.

글로벌 광의학 기술 시장 보고서는 약 62개의 표, 62개의 그림, 그리고 182페이지 분량으로 구성될 예정입니다.
대상 고객 (2024년 기준)
• 제조업체/구매자
• 산업 투자자/투자은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
The global photomedicine technology market reached US$ 3.6 billion in 2023 and is expected to reach US$ 6.7 billion by 2031, growing at a CAGR of 8.2% during the forecast period 2024-2031.
The field of medicine known as photomedicine uses light and photobiology to treat diseases. Technologies in photomedicine are employed for a range of therapeutic and diagnostic applications. Photomedicine technologies are more advanced than traditional disease detection methods and are used to treat a wide range of therapy areas such as oncology, ophthalmology, dentistry, dermatology pain management, and others.
The market is driven by factors such as the increasing adoption of advanced laser-based treatments, increased awareness of aesthetics, and rising awareness about non-invasive procedures & technological advancements.
Market Dynamics: Drivers
Increasing adoption of advanced laser-based treatments
The demand for the global photomedicine technology market is driven by multiple factors. Laser treatments have been implemented over the new technologies available for different skin diseases. Ablative and non-ablative lasers act on different levels of the epidermis and dermis, allowing to treatment of many dermatological conditions.
Moreover, the integration of laser technology and artificial intelligence would drive this market growth. As per Asclepion laser technology publication in January 2024, the integration of AI with laser devices is indicating a new era, offering practitioners unprecedented precision, efficiency, and outcomes that seamlessly achieve their patients’ aesthetic goals.
In addition, key players in the industry introducing new treatments and approvals would propel this market growth. For instance, in November 2022, the US Food and Drug Administration (FDA) cleared Accure Acne, Inc.’s Accure Laser System for the treatment of mild to severe inflammatory acne vulgaris. Accure’s system is the first 1726nm-based laser device with both FDA and CE Mark clearances.
Also, in April 2024, ViaLase announces the closure of the financing series with $40 million for laser advancement. The development of a laser system that performs femtosecond laser image-guided high-precision trabeculectomy.
Restraints
Factors such as adverse effects & complications associated with the treatment, the high cost of photomedicine procedures, lack of skilled professionals, and limited regulatory framework & reimbursement policies are expected to hamper the market.
For more details on this report - Request for Sample
Segment Analysis
The global photomedicine technology market is segmented based on technology, application, end-user, and region.
The oncology segment accounted for approximately 54.6% of the global photomedicine technology market share
The oncology segment is expected to hold the largest market share over the forecast period. Skin carcinoma is one of the most dangerous types of cancer & fifth most commonly reported cancer in the world. As per BMC research publication in January 2023, the American Academy of Dermatology (AAD) disclosed that approximately 9,500 people in the United States were diagnosed with skin cancer every day in 2022.
In addition, key players in the market launching innovative technologies in treating various diseases and research studies would propel this market growth. According to an EurekAlert news release in December 2023, ultrafast laser technology could offer improved cancer treatment discovery by the Canadian research team at INRS could lead to more effective use of radiation therapy in oncology.
As per the AAAS publication in March 2022, Biologists and physicists at Lawrence Berkeley National Laboratory (Berkeley Lab) have teamed up to create new opportunities for cancer treatment using laser-generated proton beams.
Moreover, key players launching new products and approvals would drive this market growth. For instance, in January 2024, AngioDynamics, Inc. announced that the United States Food and Drug Administration (FDA) has cleared the Auryon XL Catheter, a 225-cm radial access catheter, for use with the Auryon Atherectomy System in the treatment of Peripheral Arterial Disease (PAD).
Geographical Analysis
North America accounted for approximately 43.4% of the global photomedicine technology market share
North America region is expected to hold the largest market share over the forecast period. The high incidence of skin disorders and cancers in North America, particularly in the United States, drives the demand for advanced photomedicine technologies. According to the American Cancer Society's 2022 update, there were an estimated 1.9 million new cancer cases in the United States, with breast cancer alone accounting for 290,560 new cases.
Moreover, side effects associated with cancer such as hair loss and skin problems drive this market growth. According to the American Hair Loss Association estimated that more than 80 million men and women are suffering from hair loss concerns in the US with a 400% increase in patient demand since the pandemic in 2022.
In addition, major players in this region launched new product launches, and approvals would drive this market growth. For instance, in March 2022, Alma announced the commercial launch of two game-changing additions to Alma’s U.S. portfolio of products this year. Alma TED and CBD+ Professional Skincare Solution were launched at the American Academy of Dermatology.
Similarly, in April 2024, Bestqool launched an FDA class-II cleared, durable, and versatile variety of red light therapy (RLT), unique devices designed to handle various skin problems & have medical-grade product certification, like alleviating symptoms of eczema and improving skin health.
Also, in July 2021, Cytrellis announced that the U.S. Food and Drug Administration has cleared their first proprietary product, the ellacor system with Micro-Coring technology, for the treatment of moderate to severe wrinkles in the mid to lower face. This minimally-invasive, first-in-category device safely and effectively removes micro-sized portions of excess skin without surgery, thermal energy, or evidence of scarring.
Similarly, in January 2024, Iridex launches new Iridex 532 and Iridex 577 Lasers in the US market marking 35 years of laser innovation in treating retina disorders & glaucoma.
Market Segmentation
By Technology
• Photodynamic Therapy
• Photoimmune Therapy
• Lasers
• Others
By Application
• Aesthetics & Dermatology
o Hair Removal
o Tattoo Removal
o Skin Resurfacing
o Other Applications
• Ophthalmology
• Dentistry
• Oncology
• Pain Management
• Wound Healing
• Other Applications
By End-use
• Hospitals & Clinics
• Cosmetic Centers
• Academics & Research Institutions
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the photomedicine technology market include Candela Corporation, Alma Lasers, Lumenis Be Ltd, PhotoMedex, biolitec Holding GmbH & Co KG, Beurer, Lumibird Medical, Koninklijke Philips N.V., THOR Photomedicine Ltd, and Johnson & Johnson among others.
Key Developments
 In May 2024, the Photomedicine to Enhance Military Readiness Program, a part of the Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR), was launched in 2018 with support from the Defense Health Agency to help prevent and treat musculoskeletal injuries.
 In March 2024, Pioneering biopharmaceutical company CLINUVEL hosted a wide-ranging market briefing discussing its novel drug SCENESSE (afamelanotide) and the future of photomedicine.
 In May 2022, Lumenis Be stated that OptiLight has received the highly competitive MedTech Breakthrough Award for “Best New Technology Solution for Ophthalmology.”
 In January 2021, TheraLight, LLC, announced that Health Canada has approved the TheraLight 360 full-body photobiomodulation system for use in Canada. Which incorporates next-generation light therapy technology for advanced pain relief and recovery.
Why Purchase the Report?
• To visualize the global photomedicine technology market segmentation based on technology, application, end-user, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of global photomedicine technology market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in Excel consisting of key products of all the major players.
The global photomedicine technology market report would provide approximately 62 tables, 62 figures, and 182 Pages.
Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

Table of Contents
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Technology
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Adoption of Advanced Laser-based Treatments
4.1.1.2. Increased Awareness of Aesthetics
4.1.1.3. Rising awareness about non-invasive procedures & Technological Advancements
4.1.2. Restraints
4.1.2.1. Adverse Effects & Complications Associated with the Treatment
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
6. By Technology
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
6.1.2. Market Attractiveness Index, By Type
6.2. Photodynamic Therapy *
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Photoimmune Therapy
6.4. Lasers
6.5. Others
7. By Application
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Aesthetics & Dermatology *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.2.3. Hair Removal
7.2.4. Tattoo Removal
7.2.5. Skin Resurfacing
7.2.6. Other Applications
7.3. Ophthalmology
7.4. Dentistry
7.5. Oncology
7.6. Pain Management
7.7. Wound Healing
7.8. Other Applications
8. By End-User
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals & Clinics *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cosmetic Centers
8.4. Academics & Research Institutions
8.5. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. UK
9.3.6.3. France
9.3.6.4. Italy
9.3.6.5. Spain
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. South Korea
9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Candela Corporation *
11.1.1. Company Overview
11.1.2. Product Portfolio & Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Alma Lasers
11.3. Lumenis Be Ltd
11.4. PhotoMedex
11.5. biolitec Holding GmbH & Co KG
11.6. Beurer
11.7. Lumibird Medical
11.8. Koninklijke Philips N.V.
11.9. THOR Photomedicine Ltd
11.10. Johnson & Johnson
LIST NOT EXHAUSTIVE
12. Appendix
12.1. About Us and Services
12.2. Contact Us

언급된 주요 기업들

Candela Corporation, 4. Key Developments, Alma Lasers, Lumenis Be Ltd, PhotoMedex, biolitec Holding GmbH & Co KG, Beurer, Lumibird Medical, Koninklijke Philips N.V., THOR Photomedicine Ltd, Johnson & Johnson

표 목록 (Tables)

List of Tables

Table 1 Global Photomedicine Technology Market Value, By Technology, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Photomedicine Technology Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Photomedicine Technology Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Photomedicine Technology Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Photomedicine Technology Market Value, By Technology, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Photomedicine Technology Market Value, By Technology, 2022-2031 (US$ Million)

Table 7 Global Photomedicine Technology Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 8 Global Photomedicine Technology Market Value, By Application, 2022-2031 (US$ Million)

Table 9 Global Photomedicine Technology Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)

Table 10 Global Photomedicine Technology Market Value, By End-User, 2022-2031 (US$ Million)

Table 11 Global Photomedicine Technology Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 12 Global Photomedicine Technology Market Value, By Region, 2022-2031 (US$ Million)

Table 13 North America Photomedicine Technology Market Value, By Technology, 2022-2031 (US$ Million)

Table 14 North America Photomedicine Technology Market Value, By Application, 2022-2031 (US$ Million)

Table 15 North America Photomedicine Technology Market Value, By End-User, 2022-2031 (US$ Million)

Table 16 North America Photomedicine Technology Market Value, By Country, 2022-2031 (US$ Million)

Table 17 Asia-Pacific Photomedicine Technology Market Value, By Technology, 2022-2031 (US$ Million)

Table 18 Asia-Pacific Photomedicine Technology Market Value, By Application, 2022-2031 (US$ Million)

Table 19 Asia-Pacific Photomedicine Technology Market Value, By End-User, 2022-2031 (US$ Million)

Table 20 Asia-Pacific Photomedicine Technology Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Europe Photomedicine Technology Market Value, By Technology, 2022-2031 (US$ Million)

Table 22 Europe Photomedicine Technology Market Value, By Application, 2022-2031 (US$ Million)

Table 23 Europe Photomedicine Technology Market Value, By End-User, 2022-2031 (US$ Million)

Table 24 Europe Photomedicine Technology Market Value, By Country, 2022-2031 (US$ Million)

Table 25 South America Photomedicine Technology Market Value, By Technology, 2022-2031 (US$ Million)

Table 26 South America Photomedicine Technology Market Value, By Application, 2022-2031 (US$ Million)

Table 27 South America Photomedicine Technology Market Value, By End-User, 2022-2031 (US$ Million)

Table 28 South America Photomedicine Technology Market Value, By Country, 2022-2031 (US$ Million)

Table 29 Middle East and Africa Photomedicine Technology Market Value, By Technology, 2022-2031 (US$ Million)

Table 30 Middle East and Africa Photomedicine Technology Market Value, By Application, 2022-2031 (US$ Million)

Table 31 Middle East and Africa Photomedicine Technology Market Value, By End-User, 2022-2031 (US$ Million)

Table 32 Middle East and Africa Photomedicine Technology Market Value, By Country, 2022-2031 (US$ Million)

Table 33 Candela Corporation: Overview

Table 34 Candela Corporation: Product Portfolio

Table 35 Candela Corporation: Key Developments

Table 36 Alma Lasers: Overview

Table 37 Alma Lasers: Product Portfolio

Table 38 Alma Lasers: Key Developments

Table 39 Lumenis Be Ltd: Overview

Table 40 Lumenis Be Ltd: Product Portfolio

Table 41 Lumenis Be Ltd: Key Developments

Table 42 PhotoMedex: Overview

Table 43 PhotoMedex: Product Portfolio

Table 44 PhotoMedex: Key Developments

Table 45 biolitec Holding GmbH & Co KG: Overview

Table 46 biolitec Holding GmbH & Co KG: Product Portfolio

Table 47 biolitec Holding GmbH & Co KG: Key Developments

Table 48 Beurer: Overview

Table 49 Beurer: Product Portfolio

Table 50 Beurer: Key Developments

Table 51 Lumibird Medical: Overview

Table 52 Lumibird Medical: Product Portfolio

Table 53 Lumibird Medical: Key Developments

Table 54 Koninklijke Philips N.V.: Overview

Table 55 Koninklijke Philips N.V.: Product Portfolio

Table 56 Koninklijke Philips N.V.: Key Developments

Table 57 THOR Photomedicine Ltd: Overview

Table 58 THOR Photomedicine Ltd: Product Portfolio

Table 59 THOR Photomedicine Ltd: Key Developments

Table 60 Johnson & Johnson: Overview

Table 61 Johnson & Johnson: Product Portfolio

Table 62 Johnson & Johnson: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 2 Global Photomedicine Technology Market Share, By Technology, 2023 & 2031 (%)

Figure 3 Global Photomedicine Technology Market Share, By Application, 2023 & 2031 (%)

Figure 4 Global Photomedicine Technology Market Share, By End-User, 2023 & 2031 (%)

Figure 5 Global Photomedicine Technology Market Share, By Region, 2023 & 2031 (%)

Figure 6 Global Photomedicine Technology Market Y-o-Y Growth, By Technology, 2023-2031 (%)

Figure 7 Photodynamic Therapy Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 8 Photoimmune Therapy Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 9 Lasers Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 10 Others Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 11 Global Photomedicine Technology Market Y-o-Y Growth, By Application, 2023-2031 (%)

Figure 12 Aesthetics & Dermatology Application in Global Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 13 Hair Removal Application in Global Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 14 Tattoo Removal Application in Global Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 15 Skin Resurfacing Application in Global Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 16 Other Applications Application in Global Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 17 Ophthalmology Application in Global Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 18 Dentistry Application in Global Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 19 Oncology Application in Global Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 20 Pain Management Application in Global Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 21 Wound Healing Application in Global Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 22 Other Applications Application in Global Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 23 Global Photomedicine Technology Market Y-o-Y Growth, By End-User, 2023-2031 (%)

Figure 24 Hospitals & Clinics End-User in Global Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 25 Cosmetic Centers End-User in Global Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 26 Academics & Research Institutions End-User in Global Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 27 Others End-User in Global Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 28 Global Photomedicine Technology Market Y-o-Y Growth, By Region, 2023-2031 (%)

Figure 29 North America Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 30 North America Photomedicine Technology Market Share, By Technology, 2023 & 2031 (%)

Figure 31 North America Photomedicine Technology Market Share, By Application, 2023 & 2031 (%)

Figure 32 North America Photomedicine Technology Market Share, By End-User, 2023 & 2031 (%)

Figure 33 North America Photomedicine Technology Market Share, By Country, 2023 & 2031 (%)

Figure 34 Asia-Pacific Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 35 Asia-Pacific Photomedicine Technology Market Share, By Technology, 2023 & 2031 (%)

Figure 36 Asia-Pacific Photomedicine Technology Market Share, By Application, 2023 & 2031 (%)

Figure 37 Asia-Pacific Photomedicine Technology Market Share, By End-User, 2023 & 2031 (%)

Figure 38 Asia-Pacific Photomedicine Technology Market Share, By Country, 2023 & 2031 (%)

Figure 39 Europe Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 40 Europe Photomedicine Technology Market Share, By Technology, 2023 & 2031 (%)

Figure 41 Europe Photomedicine Technology Market Share, By Application, 2023 & 2031 (%)

Figure 42 Europe Photomedicine Technology Market Share, By End-User, 2023 & 2031 (%)

Figure 43 Europe Photomedicine Technology Market Share, By Country, 2023 & 2031 (%)

Figure 44 South America Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 45 South America Photomedicine Technology Market Share, By Technology, 2023 & 2031 (%)

Figure 46 South America Photomedicine Technology Market Share, By Application, 2023 & 2031 (%)

Figure 47 South America Photomedicine Technology Market Share, By End-User, 2023 & 2031 (%)

Figure 48 South America Photomedicine Technology Market Share, By Country, 2023 & 2031 (%)

Figure 49 Middle East and Africa Photomedicine Technology Market Value, 2022-2031 (US$ Million)

Figure 50 Middle East and Africa Photomedicine Technology Market Share, By Technology, 2023 & 2031 (%)

Figure 51 Middle East and Africa Photomedicine Technology Market Share, By Application, 2023 & 2031 (%)

Figure 52 Middle East and Africa Photomedicine Technology Market Share, By End-User, 2023 & 2031 (%)

Figure 53 Candela Corporation: Financials

Figure 54 Alma Lasers: Financials

Figure 55 Lumenis Be Ltd: Financials

Figure 56 PhotoMedex: Financials

Figure 57 biolitec Holding GmbH & Co KG: Financials

Figure 58 Beurer: Financials

Figure 59 Lumibird Medical: Financials

Figure 60 Koninklijke Philips N.V.: Financials

Figure 61 THOR Photomedicine Ltd: Financials

Figure 62 Johnson & Johnson: Financials